According to the latest report by IMARC Group, titled, “Vaccine Adjuvants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026“, the global vaccine adjuvants market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 12% during 2021-2026.

Vaccine adjuvants refer to compounds that enhance the immunogenic reaction of the body against antigens that have insufficient immunostimulatory capabilities. An adjuvant refers to an ingredient that is utilized to create a stronger immune response in people receiving the vaccine. Vaccines comprise weakened or dead germs which elicit the immune response and activate antigen-presenting cells (APCs). This reaction assists the body in increasing its ability to induce long-term protection and safety against related infections. Some of the commonly available vaccine adjuvants that are feasible for human use include aluminum salts and MF59, which is an oil-in-water emulsion made up of squalene.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/vaccine-adjuvants-market/requestsample

Market Trends

The increasing prevalence of allergies and infectious diseases, such as cancer, human immunodeficiency virus (HIV/AIDS), human papillomavirus (HPV), tuberculosis, etc., is driving the vaccine adjuvants market globally. Additionally, the rising need for advanced treatment options for existing and emerging fatal diseases has resulted in the development of vaccines that have long-lasting effects on immunization, which is further catalyzing the market growth. Besides this, the improving healthcare infrastructures and the growing levels of investments in research and development (RD) of new therapeutics are further propelling the product demand. Moreover, the sudden outbreak of the COVID-19 pandemic is escalating the requirement for effective and safe vaccine adjuvants, which is anticipated to fuel the market growth in the coming years.

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Adjuvance Tecchnologies Inc.
Adjuvatis
Agenus Inc.
Brenntag SE
Chemtrade Logistics Inc.
CSL Limited
Croda International Plc
Invivogen
Novavax Inc.
OZ Biosciences
Virometix AG.

The report has segmented the market based on product type, route of administration, diseases and application.

Breakup by Product Type:
Adjuvant Emulsions
Pathogen Components
Particulate Adjuvants
Combination Adjuvants
Others

Breakup by Route of Administration:
Oral
Intramuscular
Intranasal
Subcutaneous
Intradermal
Others

Breakup by Diseases:
Cancer
Infectious Diseases
Others

Breakup by Application:
Research
Commercial

Breakup by Region:
North America
Asia-Pacific
Europe
Latin America
Middle East and Africa

Ask Customization and Browse full report with TOC List of Figure: https://bit.ly/2UNDdhq

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.